SCHEMBL5365571

SCHEMBL5365571

COc1ccc(-c2ccc(CO)nc2-c2ccc(OC)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.50
PDE10A Q9Y233 1/20 0.50
MEN1 O00255 1/20 0.50
ESR2 Q92731 1/20 0.44
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
NOX1 Q9Y5S8 1/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
MAPK10 P53779 1/20 0.43
PTK2B Q14289 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811479 0.84 ESR2 (0.51) KMT2AMEN1ESR2KDM4ELMNA
Hydrochloric Acid SCHEMBL5362197 0.84 KMT2A (0.51) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL5358033 0.83 KMT2A (0.47) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL5362511 0.83 MAOB (0.50) KMT2AMEN1KDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL9695296 0.81 KMT2A (0.46) KMT2AMEN1KDM4EALDH1A1LMNA
Hydrochloric Acid SCHEMBL9695713 0.81 MAOB (0.51) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL5365533 0.81 GAA (0.51) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL9695238 0.80 ALDH1A1 (0.49) KMT2AMEN1KDM4EALDH1A1LMNA
SCHEMBL19835441 0.77 NOTUM (0.45) PDE10AKDM4ELMNAL3MBTL1MAPT
SCHEMBL2833283 0.77 S1PR3 (0.51) KMT2APDE10AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271266-B2 Substituted 2,3-diphenyl pyridines MERCK & CO., INC. (US) 2007-09-18 US disclosed
US-20050182103-A1 Substituted 2,3-diphenyl pyridines MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1492784-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES Merck & Co., Inc. (US) 2005-01-05 EP disclosed
WO-2003082191-A2 SUBSTITUTED 2,3-DIPHENYL PYRIDINES MERCK & CO., INC. (US) 2003-10-09 WO disclosed
WO-1992002513-A1 HETEROCYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182103-A1 Substituted 2,3-diphenyl pyridines CNR1, CNR2, MAG KMT2A 2706/4885PDE10A 1793/4885MEN1 415/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.